
Browsing restrictions can be lifted for a fee.
-0.12%
Xoma royalty corp.
0.93%
Avg of Sector
0.67%
S&P500
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
Unit : USD
| QTR | Non-GAAP EPS | EPS YoY | EPS Surprise % | Sales | Sales YoY | Sales Surprise % | NPM |
|---|---|---|---|---|---|---|---|
| Current | |||||||
| 2025Q4 | |||||||
| 2025Q3 | |||||||
| 2025Q2 | |||||||
| 2025Q1 |
The most recent financial report for Xoma royalty corp. (XOMA) covers the period of 2025Q4 and was published on 2025/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating XOMA's short-term business performance and financial health. For the latest updates on XOMA's earnings releases, visit this page regularly.
According to historical valuation range analysis, Xoma royalty corp. (XOMA)'s current price-to-earnings (P/E) ratio is 17.59, placing it in the Watch zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning optimistic. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.
According to the latest financial report, Xoma royalty corp. (XOMA) reported an Operating Profit of 2.18M with an Operating Margin of 15.86% this period, representing a growth of 130.08% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.
In the latest financial report, Xoma royalty corp. (XOMA) announced revenue of 13.76M, with a Year-Over-Year growth rate of 57.87%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.
As of the end of the reporting period, Xoma royalty corp. (XOMA) had total debt of 131.56M, with a debt ratio of 0.48. Long-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.
At the end of the period, Xoma royalty corp. (XOMA) held Total Cash and Cash Equivalents of 88.35M, accounting for 0.32 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.
In the latest report, Xoma royalty corp. (XOMA) achieved the “three margins increasing” benchmark, with a gross margin of 100%%, operating margin of 15.86%%, and net margin of 24.2%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess XOMA's profit trajectory and future growth potential.
According to the past four quarterly reports, Xoma royalty corp. (XOMA)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 0.27. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.
Xoma royalty corp. (XOMA)'s Free Cash Flow (FCF) for the period is -5.34M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 66.46% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.
The latest valuation data shows Xoma royalty corp. (XOMA) has a Price-To-Earnings (PE) ratio of 17.59 and a Price/Earnings-To-Growth (PEG) ratio of -0.31. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.